Israel Englander Acumen Pharmaceuticals, Inc. Transaction History
Millennium Management LLC
- $224 Billion
- Q1 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 2,629,541 shares of ABOS stock, worth $5.63 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,629,541
Previous 1,495,284
75.86%
Holding current value
$5.63 Million
Previous $5.74 Million
85.49%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ABOS
# of Institutions
84Shares Held
26.8MCall Options Held
319KPut Options Held
86.3K-
Sands Capital Ventures, LLC Arlington, VA3.42MShares$7.31 Million4.42% of portfolio
-
Franklin Resources Inc San Mateo, CA3.4MShares$7.27 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.3MShares$4.92 Million0.24% of portfolio
-
Laurion Capital Management LP New York, NY1.9MShares$4.06 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.67MShares$3.56 Million0.0% of portfolio
About Acumen Pharmaceuticals, Inc.
- Ticker ABOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,503,100
- Market Cap $86.7M
- Description
- Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...